An immune-cell signature of bacterial sepsis
Top Cited Papers
- 17 February 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 26 (3), 333-340
- https://doi.org/10.1038/s41591-020-0752-4
Abstract
Dysregulation of the immune response to bacterial infection can lead to sepsis, a condition with high mortality. Multiple whole-blood gene-expression studies have defined sepsis-associated molecular signatures, but have not resolved changes in transcriptional states of specific cell types. Here, we used single-cell RNA-sequencing to profile the blood of people with sepsis (n = 29) across three clinical cohorts with corresponding controls (n = 36). We profiled total peripheral blood mononuclear cells (PBMCs, 106,545 cells) and dendritic cells (19,806 cells) across all subjects and, on the basis of clustering of their gene-expression profiles, defined 16 immune-cell states. We identified a unique CD14+ monocyte state that is expanded in people with sepsis and validated its power in distinguishing these individuals from controls using public transcriptomic data from subjects with different disease etiologies and from multiple geographic locations (18 cohorts, n = 1,467 subjects). We identified a panel of surface markers for isolation and quantification of the monocyte state and characterized its epigenomic and functional phenotypes, and propose a model for its induction from human bone marrow. This study demonstrates the utility of single-cell genomics in discovering disease-associated cytologic signatures and provides insight into the cellular basis of immune dysregulation in bacterial sepsis.Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U24AI118668, U24AI118668)
- David P. Ryan, MD Endowed Chair in Cancer Research
- U.S. Department of Health & Human Services | National Institutes of Health (1K08AI119157-04)
- U.S. Department of Health & Human Services | Biomedical Advanced Research and Development Authority (1DSEP160030-01-00)
- Burroughs Wellcome Fund
- Allergan Foundation
- Broad Institute
- Ellison Foundation
This publication has 53 references indexed in Scilit:
- The Next Generation of Sepsis Clinical Trial DesignsCritical Care Medicine, 2014
- Circulating Mitochondrial DNA in Patients in the ICU as a Marker of Mortality: Derivation and ValidationPLoS Medicine, 2013
- Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approachThe Lancet Infectious Diseases, 2013
- Inflammasome-regulated Cytokines Are Critical Mediators of Acute Lung InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shockIntensive Care Medicine, 2010
- Dysfunctional expansion of hematopoietic stem cells and block of myeloid differentiation in lethal sepsisBlood, 2009
- Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shockCritical Care Medicine, 2007
- Transcription factors in myeloid development: balancing differentiation with transformationNature Reviews Immunology, 2007
- 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceCritical Care Medicine, 2003
- 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceIntensive Care Medicine, 2003